Newamsterdam Pharma Company Nv (NAMS)

May 10, 2025

Barclays PLC Buys 9,117 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 10, 2025

May 10, 2025

Needham & Company LLC Issues Pessimistic Forecast for NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price - Defense World

May 10, 2025

May 09, 2025

NewAmsterdam Pharma Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

NewAmsterdam Pharma Q1 Net Loss Narrows, Revenue Rises - marketscreener.com

May 08, 2025

May 08, 2025

NewAmsterdam Pharma Company NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

May 08, 2025

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025

May 08, 2025

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - GlobeNewswire

May 08, 2025

May 08, 2025

Ratios Revealed: Decoding NewAmsterdam Pharma Company NV (NAMS)’s Financial Health - DWinneX

May 08, 2025

May 08, 2025

Earnings Flash (NAMS) NewAmsterdam Pharma Co. NV Reports Q1 Revenue $2.98M, vs. FactSet Est of $1.6M - marketscreener.com

May 08, 2025

May 08, 2025

NewAmsterdam Pharma Q1 2025 Financial Results and Corporate Update - TradingView

May 08, 2025

May 08, 2025

NewAmsterdam Pharma Company N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

Envestnet Asset Management Inc. Sells 8,738 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 08, 2025

May 07, 2025

NewAmsterdam Pharma Announces Late-Breaking Data from - GlobeNewswire

May 07, 2025

May 07, 2025

NewAmsterdam Pharma (NAMS) Reveals Promising Phase 3 Study Results for Obicetrapib | NAMS Stock News - GuruFocus

May 07, 2025

May 07, 2025

NewAmsterdam Pharma Presents Promising Phase 3 Trial Data - TipRanks

May 07, 2025

May 07, 2025

NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025 - Stock Titan

May 07, 2025

May 03, 2025

Trend Tracker for (NAMS) - news.stocktradersdaily.com

May 03, 2025

May 03, 2025

Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) PT at $43.33 - Defense World

May 03, 2025

May 02, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 02, 2025

May 02, 2025

NewAmsterdam Pharma Expands Clinical Team with 11 New Hires, Awards $4M in Equity Grants - Stock Titan

May 02, 2025

May 01, 2025

Examining NewAmsterdam Pharma Company NV (NAMS) stock is warranted - uspostnews.com

May 01, 2025

Apr 30, 2025

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

Major Breakthrough: NewAmsterdam Reveals Multiple Phase 3 Trial Results for Novel Heart Drug - Stock Titan

Apr 30, 2025

Apr 30, 2025

Geode Capital Management LLC Raises Holdings in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 30, 2025

Apr 29, 2025

NewAmsterdam Pharma Company N.V. (NAMS): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential - Insider Monkey

Apr 29, 2025

Apr 29, 2025

Legal & General Group Plc Acquires 4,556 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 29, 2025

Apr 28, 2025

Invesco Ltd. Invests $3.87 Million in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 28, 2025

Apr 26, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Purchased by JPMorgan Chase & Co. - Defense World

Apr 26, 2025

Apr 25, 2025

A closer look at NewAmsterdam Pharma Company NV (NAMS)’s stock price trends - uspostnews.com

Apr 25, 2025

Apr 23, 2025

Is NewAmsterdam Pharma Company N.V. (NAMS) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey

Apr 23, 2025

Apr 23, 2025

(NAMSW) Trading Report - news.stocktradersdaily.com

Apr 23, 2025

Apr 22, 2025

11 Best Guru Stocks to Buy According to Wall Street Analysts - Insider Monkey

Apr 22, 2025

Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025

Apr 18, 2025

Is NewAmsterdam Pharma Company NV (NASDAQ: NAMS) A Good Investment Now? - Stocksregister

Apr 18, 2025

Apr 18, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 18, 2025

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors - The Manila Times

Apr 18, 2025

Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board By Investing.com - Investing.com South Africa

Apr 17, 2025

Apr 17, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares - Investing.com Australia

Apr 17, 2025

Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board - Investing.com

Apr 17, 2025

Apr 17, 2025

Blockbuster Drug Veteran Who Led $12B Pfizer Unit Joins NewAmsterdam Board Before Critical Launch - Stock Titan

Apr 17, 2025

Apr 13, 2025

Arrowstreet Capital Limited Partnership Acquires New Shares in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 13, 2025

Apr 12, 2025

Sei Investments Co. Sells 14,456 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 12, 2025

Apr 11, 2025

NewAmsterdam Pharma (NAMS): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey

Apr 11, 2025

Apr 09, 2025

KLP Kapitalforvaltning AS Purchases Shares of 6,000 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 09, 2025

Apr 08, 2025

The Analyst Verdict: NewAmsterdam Pharma Co In The Eyes Of 6 Experts - Benzinga

Apr 08, 2025

Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 52-Week Low – Here’s Why - Defense World

Apr 08, 2025

Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Average Price Target from Analysts - Defense World

Apr 08, 2025

Apr 07, 2025

Where are the Opportunities in (NAMSW) - news.stocktradersdaily.com

Apr 07, 2025